mRNA is a potentially powerful therapeutic class to treat many types of diseases.
Unlike traditional biologics, mRNA must be encapsulated within lipid nanoparticles (LNPs) to protect it from degradation and to facilitate its delivery to targeted cells. Characterization of mRNA and LNPs presents unique challenges that require new technologies and solutions.
Access this toolkit to learn about innovative analytical solutions that cover a wide range of analytical needs, and to achieve confident characterization of an extensive list of critical quality attributes (CQAs) to meet regulatory requirements.
Learn an automated, high-throughput workflow for the rapid characterization and direct sequence mapping of large RNA and mRNA molecules.
Discover innovative analytical solutions to meet the wide range of analytical needs for mRNA vaccines and therapeutics. Achieve confident characterization of the extensive list of critical quality attributes (CQAs) to meet regulatory requirements.
Why vaccine developers need charged aerosol detectors
Πρέπει να έχετε συνδεθεί για να σχολιάσετε.